-transparent.png){kind=logo}
Oral administration of deoxycytidine simultaneously with intraperitoneal injections of cytosine arabinoside reduced toxicosis preventing drug death of mice with L1210 leukemia. These animals developed a marked antitumor effect having the median survival time (MST) considerably longer than that of untreated animals or of those receiving either of these drugs alone. At the optimal dose schedule 23% of mice survived 60 days. Under similar conditions mice with myeloid Graffi leukemia showed no antitumor response.
Related Publications
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
March 1978,
Biulleten' eksperimental'noi biologii i meditsiny,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
April 1973,
Cancer research,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
June 1987,
Seminars in oncology,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
October 1977,
Gan,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
May 1973,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
July 1986,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
December 1995,
Leukemia research,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
October 1975,
Gan,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
December 1975,
Gan,
V M Buchman, and
G J Svet-Maoldavsky, and
M R Lichinitser, and
D M Mkheidze
January 1975,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
